Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Current Oncology (Toronto, Ont.)
|
March 26, 2025
Lung Cancer: Targeted Therapy in 2025
Nicole Bouchard, Nathalie Daaboul
Advances in Therapy
|
May 22, 2025
Driving Best Practices Throughout the Treatment Journey for Patients with NSCLC with Actionable Alterations: A Podcast Discussion
Christine M Bestvina, Chul Kim, Nathalie Daaboul
Expert Review of Anticancer Therapy
|
May 7, 2026
LUMINATE-101-Maccabi: a real-world study of treatment patterns and clinical outcomes in patients with non-squamous metastatic non-small cell lung cancer in an Israeli health maintenance organization (HMO)
Sarah Sharman Moser, Alona Zer, Andre Hejazi, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies
Parneet K Cheema, Kirstin A Perdrizet, Randeep S Sangha, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2020
High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study
Arielle Elkrief, Antoine Desilets, Neha Papneja, et al.
JTO Clinical and Research Reports
|
June 29, 2026
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial
Nicolas Girard, Jonathan Goldman, Shun Lu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 26, 2020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study
Antoine Desilets, Félix Blanc-Durand, Sally Lau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2024
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous <i>EGFR</i>-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial
D Ross Camidge, Jair Bar, Hidehito Horinouchi, et al.
Current Oncology (Toronto, Ont.)
|
June 2, 2021
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019
Joanna Gotfrit, Rachel Goodwin, Timothy Asmis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Current Oncology (Toronto, Ont.)
|
March 26, 2025
Lung Cancer: Targeted Therapy in 2025
Nicole Bouchard, Nathalie Daaboul
Advances in Therapy
|
May 22, 2025
Driving Best Practices Throughout the Treatment Journey for Patients with NSCLC with Actionable Alterations: A Podcast Discussion
Christine M Bestvina, Chul Kim, Nathalie Daaboul
Expert Review of Anticancer Therapy
|
May 7, 2026
LUMINATE-101-Maccabi: a real-world study of treatment patterns and clinical outcomes in patients with non-squamous metastatic non-small cell lung cancer in an Israeli health maintenance organization (HMO)
Sarah Sharman Moser, Alona Zer, Andre Hejazi, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies
Parneet K Cheema, Kirstin A Perdrizet, Randeep S Sangha, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2020
High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study
Arielle Elkrief, Antoine Desilets, Neha Papneja, et al.
JTO Clinical and Research Reports
|
June 29, 2026
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, <i>EGFR</i> Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial
Nicolas Girard, Jonathan Goldman, Shun Lu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 26, 2020
Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non-small cell lung cancer: A real-world multicentre study
Antoine Desilets, Félix Blanc-Durand, Sally Lau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2024
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous <i>EGFR</i>-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial
D Ross Camidge, Jair Bar, Hidehito Horinouchi, et al.
Current Oncology (Toronto, Ont.)
|
June 2, 2021
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019
Joanna Gotfrit, Rachel Goodwin, Timothy Asmis, et al.
Page
of 1